0001498341-13-000002.txt : 20131016 0001498341-13-000002.hdr.sgml : 20131016 20131015174538 ACCESSION NUMBER: 0001498341-13-000002 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20131016 DATE AS OF CHANGE: 20131015 EFFECTIVENESS DATE: 20131016 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Sound Pharmaceuticals Inc CENTRAL INDEX KEY: 0001165353 IRS NUMBER: 000000000 STATE OF INCORPORATION: WA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-92101 FILM NUMBER: 131152720 BUSINESS ADDRESS: STREET 1: 4010 STONE WAY NORTH, SUITE 120 CITY: SEATTLE STATE: WA ZIP: 98103 BUSINESS PHONE: 206-634-2559 MAIL ADDRESS: STREET 1: 4010 STONE WAY NORTH, SUITE 120 CITY: SEATTLE STATE: WA ZIP: 98103 FORMER COMPANY: FORMER CONFORMED NAME: SOUND PHARMACEUTICALS INC DATE OF NAME CHANGE: 20020117 D/A 1 primary_doc.xml X0707 D/A LIVE 0001165353 Sound Pharmaceuticals Inc 4010 STONE WAY NORTH, SUITE 120 SEATTLE WA WASHINGTON 98103 206-634-2559 WASHINGTON SOUND PHARMACEUTICALS INC Corporation true Eric Lynch 4010 Stone Way N., Suite 120 Seattle WA WASHINGTON 98103 Executive Officer Director Jonathan Kil 4010 Stone Way North, Suite 120 Seattle WA WASHINGTON 98103 Executive Officer Glenn Kawasaki 816 E. Gwinn Pl. Seattle WA WASHINGTON 98102 Director Joseph Ashley 602 W. Prospect St. Seattle WA WASHINGTON 98119 Director Paul Thompson c/o Unitron Hearing 220 Beasley Dr. Kitchner A6 ONTARIO, CANADA N2G 4X1 Director Biotechnology Decline to Disclose 06b true 9999999997-06-030602 2005-05-10 false true false 0 10000002 7563366 2436636 false 21 0 0 0 false Sound Pharmaceuticals Inc /s/ Eric Lynch Eric Lynch President & CEO 2013-10-15